
浏览全部资源
扫码关注微信
1.河南中医药大学 基础医学院,郑州 453000
2.中国中医科学院 中医基础理论研究所,北京 100700
3.郑州市中医院,郑州 453000
4.北京中医药大学 第三附属医院,北京 100029
楚天云,在读硕士,从事中医药防治慢性疼痛和情志病的临床与基础研究,E-mail:838486410@qq.com
岳广欣,博士生导师,研究员,从事情志病中医药防治基础及方证相关研究,Tel:010-64089013,E-mail:yuegx73@hotmail.com
收稿日期:2020-10-15,
网络出版日期:2021-01-26,
纸质出版日期:2021-05-05
移动端阅览
楚天云,巩子汉,弓永莉等.柴胡疏肝散联合腹针治疗慢性疼痛所致抑郁的临床观察[J].中国实验方剂学杂志,2021,27(09):94-99.
CHU Tian-yun,GONG Zi-han,GONG Yong-li,et al.Clinical Study of Chaihu Shugansan Combined with Abdominal Acupuncture on Depression Caused by Chronic Pain[J].Chinese Journal of Experimental Traditional Medical Formulae,2021,27(09):94-99.
楚天云,巩子汉,弓永莉等.柴胡疏肝散联合腹针治疗慢性疼痛所致抑郁的临床观察[J].中国实验方剂学杂志,2021,27(09):94-99. DOI: 10.13422/j.cnki.syfjx.20210722.
CHU Tian-yun,GONG Zi-han,GONG Yong-li,et al.Clinical Study of Chaihu Shugansan Combined with Abdominal Acupuncture on Depression Caused by Chronic Pain[J].Chinese Journal of Experimental Traditional Medical Formulae,2021,27(09):94-99. DOI: 10.13422/j.cnki.syfjx.20210722.
目的
2
观察柴胡疏肝散联合腹针治疗慢性疼痛所致抑郁的临床效果,探讨其机制。
方法
2
选取97例慢性疼痛所致抑郁的患者,随机分为对照组(49例)和观察组(48例)。以上两组均接受西医常规治疗,包括必要的心理干预、服用帕罗西汀。对照组内服逍遥丸治疗,观察组服用柴胡疏肝散联合腹针治疗,两组治疗时间均为6周。比较两组患者治疗前后的血清神经递质、细胞因子水平和汉密尔顿抑郁量表(HAMD)分级。
结果
2
治疗前两组患者HAMD差异无统计学意义;治疗后两组患者HAMD评分较本组治疗前均明显减小(
P
<
0.05),且观察组明显小于对照组(
P
<
0.05)。治疗前两组患者血清5-羟色胺(5-HT),去甲肾上腺素(NE),脑源性神经营养因子(BDNF)水平差异无统计学意义;治疗后两组患者血清5-HT,NE,BDNF水平较本组治疗前均明显升高(
P
<
0.05),且观察组明显高于对照组(
P
<
0.05);治疗前两组患者血清白细胞介素-6(IL-6),白细胞介素-1
β
(IL-1
β
),肿瘤坏死因子-
α
(TNF-
α
)水平差异无统计学意义,治疗后两组患者血清IL-6,IL-1
β
,TNF-
α
水平较本组治疗前均明显降低(
P
<
0.05),且观察组明显低于对照组(
P
<
0.05)。
结论
2
在心理干预,服用帕罗西汀的基础上,柴胡疏肝散与腹针相结合,发挥了两者各自的优势,标本兼治,可减轻抑郁程度,降低抑郁的分级,调节神经递质和细胞炎性因子水平,抑制炎症反应,临床疗效明显。
Objective
2
To investigate the clinical effect of Chaihu Shugansan combined with abdominal acupuncture on depression caused by chronic pain,and to explore its mechanism.
Method
2
A total of 97 patients with depression caused by chronic pain were randomly divided into control group (49 cases) and observation group (48 cases). Patients in both groups received routine western medicine treatment,including necessary psychological intervention and taking paroxetine. Control groupobservation groupcontrol group Patients in control group were treated with Xiaoyaowan,and patients in observation group were treated with Chaihu Shugansan combined with abdominal acupuncture. Both groups were treated for 6 weeks. The levels of serum neurotransmitters,cytokines and Hamilton depression rating scale(HAMD) before and after treatment were compared between two groups
.
Result
2
There was no significant difference in HAMD scores of the two groups before treatment and the HAMD scores of two groups after treatment were significantly lower than those before treatment (
P
<
0.05),and the HAMD scores in observation group were significantly lower than those in the control group (
P
<
0.05). There was no significant difference in the levels of serum 5-hydroxytryptamine (5-HT),norepinephrine (NE),and brain-derived neurotrophic factor (BDNF) between two groups before treatment. After treatment,the levels of serum 5-HT,NE,and BDNF in two groups were significantly higher than those before treatment (
P
<
0.05),and the levels in observation group were significantly higher than those in control group (
P
<
0.05). There was no significant difference in the levels of serum interleukin-6 (IL-6),interleukin-1
β
(IL-1
β
) and tumor necrosis factor-
α
(TNF-
α
) before treatment. After treatment,the levels of serum IL-6,IL-1
β
and TNF-
α
were significantly lower than those before treatment (
P
<
0.05),and the levels in observation group were significantly lower than those in control group (
P
<
0.05).
Conclusion
2
On the basis of psychological intervention and paroxetine administration,the combination of Chaihu Shugansan and abdominal acupuncture exerts their respective advantages. It treats both symptoms and root causes of depression,relieves the degree of depression,reduces the classification of depression,and regulates the levels of neurotransmitter and cellular inflammatory factors,and inhibits inflammatory response. The clinical effect is significant.
黄宏烨 , 肖进 . 针刺联合经颅磁刺激治疗卒中后抑郁临床研究 [J]. 上海针灸杂志 , 2019 , 38 ( 11 ): 1209 - 1213 .
MAES M . Depression is an inflammatory disease,but cell-mediated immune activation is the key component of depression [J]. Prog Neuropsychopharmacol Biol Psychiatry , 2011 , 35 ( 3 ): 664 - 675 .
尚立芝 , 毛梦迪 , 许二平 , 等 . 柴胡加龙骨牡蛎汤对抑郁大鼠海马组织PI3K/Akt/GSK3 β / β -catenin信号通路的影响 [J]. 中国实验方剂学杂志 , 2020 , 26 ( 23 ): 12 - 19 .
CAMPOS A C P , ANTUNES G F , MATSUMOTO M , et al . Neuroinflammation,pain and depression:an overview of the main findings [J]. Front Psychol , 2020 , 11 : 1825 .
冯殿伟 . 抑郁症治疗靶标及其药物研发进展 [J]. 中国医院药学杂志 , 2018 , 38 ( 4 ): 443 - 449 .
FEINGOLD D , BRIL S , GOOR-ARYEH I , et al . Depression level,not pain severity,is associated with smoked medical marijuana dosage among chronic pain patients [J]. J Psychosom Res , 2020 , 135 : 110130 .
YAN B , ZHU S , WANG Y , et al . Effect of acupuncture on chronic pain with depression:a systematic review [J]. Evid Based Complement Alternat Med , 2020 , doi: 10.1155/2020/7479459 http://dx.doi.org/10.1155/2020/7479459 .
费丁家 , 崔艳秋 , 沈梦萱 , 等 . 接纳承诺疗法治疗慢性疼痛的随机对照试验meta分析 [J]. 中国心理卫生杂志 , 2020 , 34 ( 8 ): 643 - 649 .
国笑 , 王瑜 , 李少源 , 等 . 抑郁与慢性疼痛共病动物模型的研究进展 [J]. 世界科学技术—中医药现代化 , 2019 , 21 ( 4 ): 689 - 695 .
谢婵娟 , 许湘华 , 欧美军 , 等 . 慢性疼痛患者接纳承诺疗法的应用研究进展 [J]. 护理学杂志 , 2018 , 33 ( 15 ): 92 - 95 .
HECKE O V , HOCKING L J , TORRANCE N , et al . Chronic pain,depression and cardiovascular disease linked through ashared genetic predisposition:analysis of a family-based cohort and twin study [J]. PLoS One , 2017 , 12 ( 2 ): e0170653 .
JANDAGHI G , FIROOZI M , ZIA-TOHIDI A . Psychological interventions for depression and anxiety:an evaluation and meta-analysis of Iranian chronic pain trials [J]. Health Promot Perspect , 2020 , 10 ( 3 ): 180 - 191 .
周瑾 , 黄菲 , 吴晓俊 . 柴胡疏肝散抗抑郁化学成分和药理作用研究进展 [J]. 中药药理与临床 , 2019 , 35 ( 2 ): 174 - 179 .
李凌江 , 周建松 . ICD-10神经症、应激相关障碍及躯体形式障碍诊断标准在中国的应用情况与修改建议 [J]. 中国心理卫生杂志 , 2009 , 23 ( 7 ): 509 - 512 .
国家中医药管理局 . 中医病证诊断疗效标准 [M]. 南京 : 南京大学出版社 , 1994 : 33 .
申茜茸 , 韦嵩 . 腹针疗法的临床应用和研究进展 [J]. 现代中西医结合杂志 , 2016 , 25 ( 5 ): 564 - 567 .
杨小军 . 齐拉西酮片联合帕罗西汀治疗难治性抑郁症的效果及对血清BDNF、5-HT、NE水平的影响 [J]. 赣南医学院学报 , 2019 , 39 ( 3 ): 253 - 255 .
宋红梅 , 翟长平 , 张俊 , 等 . 帕罗西汀联合生物反馈治疗抑郁症的临床研究 [J]. 蚌埠医学院学报 , 2018 , 43 ( 2 ): 168 - 169,173 .
曹利民 , 关珊珊 , 张鹏 . 疏肝活血汤联合百忧解胶囊对抑郁性神经症患者抑郁症状评分及血清CRP,IL-1 β ,IL-2水平的影响 [J]. 四川中医 , 2018 , 36 ( 10 ): 131 - 135 .
张素勤 , 刘宝山 , 郎娜 , 等 . 滋肾疏肝宁心方联合针灸治疗更年期抑郁症临床疗效及对患者血清雌激素和子宫内膜厚度的影响 [J]. 四川中医 , 2018 , 36 ( 2 ): 157 - 160 .
杨力强 , 纪范霞 , 陈林 , 等 . 加味柴胡疏肝散治疗冠心病合并抑郁症临床观察 [J]. 广西中医药大学报 , 2020 , 23 ( 1 ): 1 - 4 .
潘中瑛 , 赵婧 , 陈静珊 . 柴胡疏肝散联合帕罗西汀对抑郁症患者血清5-HT的影响及其安全性分析 [J]. 中医药信息 , 2018 , 35 ( 1 ): 54 - 57 .
张洪财 , 陈雁雁 , 王文姌 , 等 . 柴胡-白芍药对干预大鼠抑郁症模型的血清代谢组学研究 [J]. 中医药信息 , 2018 , 35 ( 1 ): 34 - 37 .
苏志超 , 杜鑫 , 闫华琼 , 等 . 基于“四海理论”的腹部推拿治疗慢性下腰痛伴发抑郁状态的临床随机对照研究 [J]. 天津中医药 , 2020 , 37 ( 10 ): 1136 - 1141 .
荐明 , 文雅 , 赵锦弘 . 柴胡加龙骨牡蛎汤联合腹针治疗脑卒中后抑郁疗效观察 [J]. 河南中医 , 2020 , 40 ( 2 ): 206 - 209 .
李华南 , 马永利 , 张玮 , 等 . 基于脑肠轴理论探讨腹部推拿干预中枢神经系统疾病的作用机制 [J]. 辽宁中医杂志 , 2019 , 46 ( 11 ): 2321 - 2324 .
张娥铿 , 王婧 , 张瑾 . 腹针疗法治疗卒中后抑郁症临床研究 [J]. 中医学报 , 2016 , 31 ( 10 ): 1623 - 1625 .
赵轲 , 顾大东 , 杨越 . 脑卒中后抑郁患者早期血清BDNF含量及相关因素研究 [J]. 心脑血管病防治 , 2015 , 15 ( 3 ): 194 - 196 .
鲍善娟 , 邵蓓 . 脑电仿生电刺激联合舍曲林治疗脑卒中后抑郁的疗效及对其血清5-HT、NE和BDNF水平的影响 [J]. 数理医药学杂志 , 2019 , 32 ( 11 ): 1662 - 1664 .
樊凌 , 吕爱平 , 符文彬 , 等 . 针刺对抑郁症大鼠海马5-HT、NE、BDNF水平和神经元细胞凋亡相关基因表达的影响 [J]. 中华中医药杂志 , 2016 , 31 ( 8 ): 3204 - 3207 .
刘聪 , 曲冬颖 . 产褥期抑郁症患者血清IL-1 β 、IL-2、IL-6、TNF- α 水平变化及其与病情的关系 [J]. 山东医药 , 2019 , 59 ( 32 ): 61 - 63 .
苏文君 , 曹志永 , 蒋春雷 . 抑郁症的炎症机制及诊疗新策略 [J]. 生理学报 , 2017 , 69 ( 5 ): 715 - 722 .
0
浏览量
19
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621